8-K: Crown Electrokinetics Faces Nasdaq Delisting, Plans Appeal
8-K Filing
Crown Electrokinetics Corp. receives a delisting determination from Nasdaq and intends to request reconsideration and appeal the decision.
Summary
- Crown Electrokinetics Corp. has received a delisting determination from The Nasdaq Stock Market.
- The company plans to request reconsideration from the Nasdaq Hearings Panel and appeal to the Nasdaq Listing and Hearing Review Council if necessary.
- Trading of Crown's common stock will be suspended on Nasdaq effective March 5, 2025.
- The company's stock is expected to trade on the OTC Markets Pink Current Information tier starting March 5, 2025.
- Crown states it has a strong financial position with over $20 million in cash and no debt.
- The company believes it meets Nasdaq's listing requirements, including compliance with the minimum $1.00 bid price for 22 consecutive business days prior to March 3, 2025, closing at approximately $3.40 per share.
- Crown also claims to exceed the minimum $2.5 million stockholders' equity requirement.
- The company will continue to execute its growth strategy and provide updates during the appeal process.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to the delisting notice, but the company is trying to project confidence with claims of a strong financial position and plans to appeal.
Positives
- Crown reports a strong financial position with over $20 million in cash and no debt.
- The company states it has been generating revenue through its construction business.
- Crown believes it meets Nasdaq's listing requirements, including exceeding the minimum stockholders' equity requirement.
- The company is actively securing new opportunities across all its businesses.
Negatives
- Crown has received a delisting determination from Nasdaq.
- Trading of Crown's common stock will be suspended on Nasdaq effective March 5, 2025.
- There is no assurance that the Panel will grant the Company's request for reconsideration, that any appeal will be made to, or be successful with, the Nasdaq Listing and Hearing Review Council, or that the Company will be able meet the continued listing requirements if the Company is permitted to continue trading on Nasdaq.
- Once the Company's common stock are delisted, there may be a very limited market in which the Company's common stock are traded, the Company's stockholders may find it difficult to sell their shares of common stock and the trading price of the Company's common stock may be adversely affected.
Risks
- The Nasdaq Hearings Panel may not grant the company's request for reconsideration.
- An appeal to the Nasdaq Listing and Hearing Review Council may not be successful.
- The company may not be able to meet continued listing requirements even if permitted to continue trading on Nasdaq.
- Delisting could result in a limited market for the company's stock, making it difficult for stockholders to sell shares.
- The trading price of the company's common stock may be adversely affected by the delisting.
Future Outlook
Crown will pursue a request for reconsideration and appeal the delisting determination while continuing to execute its growth strategy and provide updates as appropriate.
Management Comments
- Doug Croxall, CEO and Chairman, stated, 'Crown has taken all the necessary steps to meet Nasdaq's listing requirements, and we firmly believe the Company deserves to remain on the exchange.'
- Doug Croxall, CEO and Chairman, stated, 'With a strong financial position, over $20 million in cash, no debt, and increasing market demand, Crown is well-positioned for continued expansion.'
Industry Context
The delisting determination highlights the challenges faced by companies in maintaining Nasdaq listing compliance, particularly regarding minimum bid price requirements. This situation is not unique, as other companies in similar sectors have faced delisting notices and subsequent appeals.
Comparison to Industry Standards
- It is difficult to compare Crown's situation directly to industry standards without specific financial performance data and details on their construction projects.
- However, companies like FuelCell Energy and Ballard Power Systems have faced similar listing compliance issues in the past, requiring them to implement strategies such as reverse stock splits to regain compliance.
- The success of Crown's appeal and its ability to maintain operations on the OTC Markets will depend on its financial performance and investor confidence, similar to how other companies navigate delisting challenges.
Stakeholder Impact
- Shareholders may experience difficulty selling their shares and a potential decrease in the trading price of the stock.
- Employees may be concerned about the company's future prospects.
- Customers and suppliers may need reassurance about the company's ability to continue operations.
Next Steps
- Submit a request for reconsideration to the Nasdaq Hearings Panel.
- Appeal the determination to the Nasdaq Listing and Hearing Review Council if necessary.
- Continue executing the company's growth strategy.
- Provide updates as appropriate during the appeal process.
Key Dates
| Date | Description |
|---|---|
| December 19, 2024 | Crown received a letter from Nasdaq indicating non-compliance with the minimum $1.00 bid price requirement. |
| February 13, 2025 | Crown attended a hearing before the Nasdaq Hearings Panel regarding non-compliance with the bid price rule. |
| March 3, 2025 | Crown received a letter from the Panel denying its request to continue listing on Nasdaq. |
| March 3, 2025 | Crown's stock price closed at approximately $3.40 per share. |
| March 4, 2025 | Company issued a press release regarding receipt of Panel letter and suspension of trading on Nasdaq. |
| March 5, 2025 | Trading of Crown's common stock will be suspended on Nasdaq. |
| March 5, 2025 | Company's common stock should be eligible to trade on the OTC Markets Pink Current Information tier. |
Keywords
delisting, Nasdaq, CRKN, Crown Electrokinetics, appeal, reconsideration, OTC Markets, stock suspension, listing requirements
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.